antibodies < antibody < anticancer

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f

List of bibliographic references indexed by antibody

Number of relevant bibliographic references: 86.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000168 (2017)	Praveen Kumar Tripathi [Inde] ; Ramesh Chander Mahajan [Inde] ; Nancy Malla [Inde] ; Naveen Kumar [Inde] ; Shailja Misra Bhattacharya [Inde] ; Ranganatha Krishna Shinoy [Inde] ; Abhishek Mewara [Inde] ; Rakesh Sehgal [Inde]	Stage-specific antibody response against two larval stages of Brugia malayi in different clinical spectra of brugian filariasis
000380 (2017)	Benjamin F. Arnold [États-Unis] ; Mark J. Van Der Laan [États-Unis] ; Alan E. Hubbard [États-Unis] ; Cathy Steel [États-Unis] ; Joseph Kubofcik [États-Unis] ; Katy L. Hamlin [États-Unis] ; Delynn M. Moss [États-Unis] ; Thomas B. Nutman [États-Unis] ; Jeffrey W. Priest [États-Unis] ; Patrick J. Lammie [États-Unis]	Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels.
000788 (2017)	Dziedzom Komi De Souza [Ghana] ; Irene Offei Owusu [Ghana] ; Joseph Otchere [Ghana] ; Michelle Adimazoya [Ghana] ; Kwadwo Frempong [Ghana] ; Collins Stephen Ahorlu [Ghana] ; Daniel Adjei Boakye [Ghana] ; Michael David Wilson [Ghana]	An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa.
001203 (2016)	Amit Kumar Singh ; Loveleena Agarwal ; Krishna Lakhmani ; Chandrim Sengupta ; Ravinder Pal Singh	Detection of anti-filarial antibody among hydrocele patients living in an endemic area for filariasis
001241 (2016)	R. Kamatchi [Inde] ; J. Charumathi [Inde] ; R. Ravishankaran [Inde] ; P. Kaliraj [Inde] ; S. Meenakshisundaram [Inde]	Construction and bacterial expression of a recombinant single-chain antibody fragment against Wuchereria bancrofti SXP-1 antigen for the diagnosis of lymphatic filariasis.
001398 (2016)	Johanne Damgaard [Danemark] ; Dan W. Meyrowitsch [Danemark] ; Rwehumbiza T. Rwegoshora [Tanzanie] ; Stephen M. Magesa [Tanzanie] ; Dunstan A. Mukoko [Kenya] ; Paul E. Simonsen [Danemark]	Assessing drivers of the IgG4 antibody reactivity to recombinant antigen Bm14 in Wuchereria bancrofti endemic populations in East Africa.
001684 (2015)	K. Papp [Canada] ; D. Thaçi [Allemagne] ; K. Reich [Allemagne] ; E. Riedl [Autriche] ; R G Langley [Canada] ; J G Krueger [États-Unis] ; A B Gottlieb [États-Unis] ; H. Nakagawa [Japon] ; E P Bowman [États-Unis] ; A. Mehta [États-Unis] ; Q. Li [États-Unis] ; Y. Zhou [États-Unis] ; R. Shames [États-Unis]	Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial.
001F23 (2015)	Anizah Rahumatullah [Malaisie] ; Azimah Ahmad [Malaisie] ; Rahmah Noordin [Malaisie] ; Theam Soon Lim [Malaisie]	Delineation of BmSXP antibody V-gene usage from a lymphatic filariasis based immune scFv antibody library.
002026 (2015)	Katherine E. Mues [États-Unis] ; Patrick J. Lammie [États-Unis] ; Mitchel Klein [États-Unis] ; David G. Kleinbaum [États-Unis] ; David Addiss [États-Unis] ; Leanne M. Fox [États-Unis]	Changes in Antibody Levels during and following an Episode of Acute Adenolymphangitis (ADL) among Lymphedema Patients in Léogâne, Haiti
002061 (2015)	Rita M. Dewi [Indonésie] ; Sekar Tuti [Indonésie] ; Sitti Ganefa [Indonésie] ; Chairiyah Anwar [Indonésie] ; Ria Larasati [Indonésie] ; Endah Ariyanti [Indonésie] ; Herty Herjati [Indonésie] ; Molly Brady [États-Unis]	Brugia Rapid™ antibody responses in communities of Indonesia in relation to the results of ‘transmission assessment surveys’ (TAS) for the lymphatic filariasis elimination program
002658 (2014)	Janet Chou [États-Unis] ; Maxim Lutskiy [États-Unis] ; Erdyni Tsitsikov [États-Unis] ; Luigi D. Notarangelo [États-Unis] ; Raif S. Geha [États-Unis] ; Anahita Dioun [États-Unis]	Presence of hypogammaglobulinemia and abnormal antibody responses in 1 GATA2 deficiency
003302 (2013)	Robert H. Vonderheide [États-Unis] ; Jennifer M. Burg [États-Unis] ; Rosemarie Mick [États-Unis] ; Jennifer A. Trosko [États-Unis] ; Dongguang Li [États-Unis] ; M. Naveed Shaik [États-Unis] ; Anthony W. Tolcher [États-Unis] ; Omid Hamid [États-Unis]	Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors
003C39 (2013)	M. Vavrovsky [Autriche] ; W. Klotz [Autriche] ; M. Herold [Autriche]	AB0734 Anti-sa antibody concentration does not change with disease activity in patients with rheumatoid arthritis
005575 (2010)	Laura A. Sullivan [États-Unis] ; Rolf A. Brekken [États-Unis]	The VEGF family in cancer and antibody-based strategies for their inhibition
005A62 (2010)	Gary J. Weil [États-Unis] ; Kurt C. Curtis [États-Unis] ; Peter U. Fischer [États-Unis] ; Kimberly Y. Won [États-Unis] ; Patrick J. Lammie [États-Unis] ; Hayley Joseph [Australie] ; Wayne D. Melrose [Australie] ; Norbert W. Brattig. [Allemagne]	A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14
005F90 (2009)	Heidi H. Petersen [Danemark] ; Nina O. Nielsen ; Jesper Monrad ; Stephen M. Magesa ; Paul E. Simonsen	The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals.
006521 (2009)	Chandanapurath Shiny [Inde] ; Nagampalli S. A. Krushna [Inde] ; Bairavasundaram Archana [Inde] ; Begum Farzana [Inde] ; Rangarajan B. Narayanan [Inde]	Serum antibody responses to Wolbachia surface protein in patients with human lymphatic filariasis
006640 (2009)	Nagampalli S. A. Krushna [Inde] ; Chandanpurath Shiny [Inde] ; Srinivasan Dharanya [Inde] ; Arivazhagan Sindhu [Inde] ; Sridharan Aishwarya [Inde] ; Rangarajan B. Narayanan [Inde]	Immunolocalization and serum antibody responses to Brugia malayi pepsin inhibitor homolog (Bm‐33)
006A29 (2008)	Daniel J. Tisch ; Moses J. Bockarie ; Zachary Dimber ; Benson Kiniboro ; Nandao Tarongka ; Fred E. Hazlett ; Will Kastens ; Michael P. Alpers ; James W. Kazura	Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea: Changes in Microfilaremia, Filarial Antigen, and Bm14 Antibody after Cessation
007226 (2007)	Michael A. Morse [États-Unis] ; Amy Hobeika [États-Unis] ; Takuya Osada [États-Unis] ; Donna Niedzwiecki [États-Unis] ; Paul Kelly Marcom [États-Unis] ; Kimberly L. Blackwell [États-Unis] ; Carey Anders [États-Unis] ; Gayathri R. Devi [États-Unis] ; H Kim Lyerly [États-Unis] ; Timothy M. Clay [États-Unis]	Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2
007329 (2007)	N. Suba [Inde] ; C. Shiny ; M J Taylor ; R B Narayanan	Brugia malayi Wolbachia hsp60 IgG antibody and isotype reactivity in different clinical groups infected or exposed to human bancroftian lymphatic filariasis.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "antibody" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "antibody" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    antibody
}}

---

This area was generated with Dilib version V0.6.31. Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024